NCT03506425: A reported trial by Richard Bedlack, M.D., Ph.D.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03506425 |
|---|---|
| Title | A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 21, 2018 |
| Completion date | March 28, 2019 |
| Required reporting date | March 27, 2020, midnight |
| Actual reporting date | Nov. 20, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |